AI chatbots aim to fix overtesting in ovarian cancer screening
NCT ID NCT07503054
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a conversation with an AI can help gynecologists better understand the risks and benefits of ovarian cancer screening. Many doctors overestimate how helpful screening is for average-risk women. The study will involve 350 gynecologists and compare an AI discussion about screening evidence to one about general cancer facts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER SCREENING RECOMMENDATIONS BY GYNECOLOGISTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité - Universitätsmedizin Berlin
Mitte, State of Berlin, 10117, Germany